<ul><li>Neuralink's brain-computer interface (BCI) device, Link, has received FDA's 'breakthrough' designation for restoring communication in patients with severe speech impairment.</li><li>The Link device aims to help individuals with conditions such as ALS, stroke, spinal cord injury, cerebral palsy, and multiple sclerosis by utilizing AI to enable communication.</li><li>A participant of Neuralink's PRIME Study, Bradford G. Smith, who has ALS, showcased the device's ability to restore his communication through brain control, enhancing his communication and mobility.</li><li>Neuralink is focusing on empowering individuals with neurological conditions through innovative assistive solutions, with plans to expand trials worldwide and further develop capabilities for vision restoration and other health challenges.</li></ul>

Neuralink device gets FDA recognition for speech restoration

Discover more